B
BIIB
Biogen Inc
192.03
-0.05-0.03%After Hours: 191.22 -0.81 -0.42%19:34 02/20 EST
OPEN/PREV CLOSE190.78/192.08
TODAY RANGE189.95-192.60
VOL799.23K
MARKET CAP28.18B
52 WEEK RANGE110.04-202.41
AVG VOL (3M)1.87M
% TURNOVER0.54%
TURNOVER--
P/E (TTM)21.85
% RANGE1.37%
EPS(TTM)8.79
P/E(FORWARD)16.13
P/B1.543
BVPS124.45
DIVIDEND--
P/S2.848
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP28.12B
SHARES OUTSTANDING146.76M
NEXT EARNINGS04/29-05/04
FREE FLOAT146.46M
LOT SIZE1
EX-DATE02/02/2017
News
Press Releases
Financial Reports
Profile
Benzinga·1d ago
Beyond The Numbers: 21 Analysts Discuss Biogen Stock
TipRanks·2d ago
Biogen initiated with an Equal Weight at Barclays
Seeking Alpha·2d ago
China drug licensing deals surge nearly 10-fold in value since 2021
Simply Wall St·2d ago
Biogen (BIIB) Valuation Check After Earnings Momentum And Analyst Optimism
Seeking Alpha·3d ago
NIH director reportedly being tapped as acting CDC director
TipRanks·3d ago
Piper Sandler Keeps Their Hold Rating on Biogen (BIIB)
Simply Wall St·02/14 19:21
Biogen’s New Therapies Surpass US$1 Billion In Sales Might Change The Case For Investing In BIIB
Simply Wall St·02/13 11:25
There May Be Reason For Hope In Biogen's (NASDAQ:BIIB) Disappointing Earnings
Simply Wall St·02/12 03:30
Biogen (BIIB) Valuation Check After Q4 Beat And Momentum In New Drugs Like Leqembi
TipRanks·02/11 22:31
Biogen Announces Board Chair Caroline Dorsa to Step Down
Same Industry
Name/Symbol
Change%
Price